MedTrace Logo

Trial-specific Patient Decision Aid (tPDA) of the ImmunoSABR Phase 2

NCT04604470 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 126

Last updated 2020-10-27

No results posted yet for this study

Summary

This is a trial-specific (NCT03705403) decision aid (tPDA) for stage IV NSCLC patients that might want to participate.

We want to investigate if a tPDA would be (significantly) helpful for these patients in making a decision.

ImmunoSABR has a complex study design, we expect that the patients get a better overview of the trial via the tPDA because you can bring multiple tools together. (text, video, questions, pictures, timelines, etc.)

Conditions

Interventions

OTHER

Decision tool

no intervention.

Sponsors & Collaborators

  • Maastricht University

    lead OTHER

Principal Investigators

  • Philippe Lambin, Prof. MD · MUMC/UM

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-20
Primary Completion
2023-10-01
Completion
2023-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04604470 on ClinicalTrials.gov